EZH2: a novel target for cancer treatment
Crossref DOI link: https://doi.org/10.1186/s13045-020-00937-8
Published Online: 2020-07-28
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Duan, Ran
Du, Wenfang
Guo, Weijian http://orcid.org/0000-0002-6155-8345
Text and Data Mining valid from 2020-07-28
Version of Record valid from 2020-07-28
Article History
Received: 3 May 2020
Accepted: 13 July 2020
First Online: 28 July 2020
Ethics approval and consent to participate
: Not applicable.
: The authors declare that they have no competing interests.